M

23andMe Holding Co
D

ME

0.38450
USD
-0.0159
(-3.97%)
Market Closed
Volume
5,235
EPS
0
Div Yield
0
P/E
-4
Market Cap
2,398,487,651
Related Instruments
    CAT
    -14.73
    (-4.26%)
    331.36 USD
    DE
    -13.86
    (-3.73%)
    357.87 USD
    EMR
    -4.010
    (-3.42%)
    113.080 USD
    GE
    -0.380
    (-0.22%)
    169.750 USD
    I
    IR
    -9.170
    (-9.14%)
    91.210 USD
    K
    KMT
    -0.960
    (-3.67%)
    25.190 USD
    MMM
    -1.100
    (-0.86%)
    126.430 USD
    R
    ROK
    -13.62
    (-4.89%)
    264.67 USD
    T
    TEX
    -4.640
    (-7.33%)
    58.680 USD
News

Title: 23andMe Holding Co

Sector: Healthcare
Industry: Diagnostics & Research
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.